X
01Jul

Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)

At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China.  Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/novartis-and-alcon-fcpa-enforcement-13538/

Related

Sweeping Changes to Retirement Plan Rules Passed Under the SECURE Act – Provisions Requiring Immediate Attention

On December 20, 2019, the Further Consolidated Appropriations Act, 2020 (the “FCAA”) was signed by...

Read More >

Pay Equity Update: Oregon Legislature Amends Equal Pay Law

SB 123, just passed by the legislature and signed by Governor Brown, makes several amendments to Ore...

Read More >

Pennsylvania Court Finds Employee Can Assert Claim Against Employer Under State’s Medical Marijuana Act

The Lackawanna Court of Common Pleas in Pennsylvania held, in a matter of first impression, that lan...

Read More >

Draft Amendments To German Competition Law Published

The German Ministry for Economic Affairs and Energy has published the draft bill on the 10th amendme...

Read More >

New California Law Requires Additional Flexible Spending Account Notices

Under a California law that took effect on January 1, 2020, employers will have to provide extra not...

Read More >

Assessing Risks Under Tech Start-Up Stock Incentive Plans – When Time Doesn’t Cure All!

Depending on a tech start-up company’s initial financial condition, many tech start-ups are sometim...

Read More >